Protalix BioTherapeutics Inc. Stock, ASE:PLX
2 University Plaza, Suite 100, Hackensack, New Jersey 07601
United States of America
Number of Employees: 207
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.